901,645 Shares in Tenet Healthcare Corporation $THC Purchased by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 901,645 shares of the company’s stock, valued at approximately $168,761,000. Tenet Healthcare makes up 2.2% of Manning & Napier Advisors LLC’s portfolio, making the stock its 14th biggest position. Manning & Napier Advisors LLC owned approximately 1.12% of Tenet Healthcare at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in THC. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare in the fourth quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in Tenet Healthcare in the 4th quarter worth about $29,000. Meeder Asset Management Inc. increased its holdings in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

NYSE THC opened at $278.71 on Tuesday. The stock has a 50-day simple moving average of $222.52 and a 200 day simple moving average of $207.54. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $283.05. The stock has a market capitalization of $22.44 billion, a PE ratio of 10.75, a P/E/G ratio of 1.07 and a beta of 1.23. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the previous year, the business posted $4.02 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 20.97 EPS for the current year.

Analysts Set New Price Targets

THC has been the subject of several analyst reports. Guggenheim lifted their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Zacks Research upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Morgan Stanley raised their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. Mizuho set a $290.00 target price on Tenet Healthcare in a research report on Monday, August 10th. Finally, Barclays lifted their price target on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Tenet Healthcare has an average rating of “Buy” and an average price target of $273.00.

Insider Activity

In other Tenet Healthcare news, EVP Paola M. Arbour sold 10,878 shares of the stock in a transaction on Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the completion of the sale, the executive vice president directly owned 18,413 shares of the company’s stock, valued at $4,490,930.70. This represents a 37.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 41,375 shares of company stock worth $9,793,347. Corporate insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.